高氨血症
谷氨酸脱氢酶
高胰岛素血症
内科学
内分泌学
外显子
错义突变
低血糖
医学
高胰岛素性低血糖
重氮氧化物
突变
基因
生物
谷氨酸受体
生物化学
胰岛素
胰岛素抵抗
受体
作者
Maria Lúcia Corrêa‐Giannella,Daniel Soares Freire,Ana Mercedes Cavaleiro,Maria Angela Zanella Fortes,Ricardo Rodrigues Giorgi,Maria Adelaide Albergaria Pereira
出处
期刊:Arquivos Brasileiros De Endocrinologia E Metabologia
[SciELO]
日期:2012-11-01
卷期号:56 (8): 485-489
被引量:7
标识
DOI:10.1590/s0004-27302012000800004
摘要
The hyperinsulinism/hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease manifested by hypoglycemic symptoms triggered by fasting or high-protein meals, and by elevated serum ammonia. HI/HA is the second most common cause of hyperinsulinemic hypoglycemia of infancy, and it is caused by activating mutations in GLUD1, the gene that encodes mitochondrial enzyme glutamate dehydrogenase (GDH). Biochemical evaluation, as well as direct sequencing of exons and exon-intron boundary regions of the GLUD1 gene, were performed in a 6-year old female patient presenting fasting hypoglycemia and hyperammonemia. The patient was found to be heterozygous for one de novo missense mutation (c.1491A>G; p.Il497Met) previously reported in a Japanese patient. Treatment with diazoxide 100 mg/day promoted complete resolution of the hypoglycemic episodes. Arq Bras Endocrinol Metab. 2012;56(8):485-9
科研通智能强力驱动
Strongly Powered by AbleSci AI